Загрузка...
Evaluation of a novel autoinjector for subcutaneous self-administration of belimumab in systemic lupus erythematosus
Objective: To study self-administration and pharmacokinetics (PK) of subcutaneous (SC) belimumab in patients with systemic lupus erythematosus (SLE). Methods: Patients previously treated with belimumab self-administered belimumab 200 mg SC weekly for 8 weeks using an autoinjector. The primary endpoi...
Сохранить в:
| Опубликовано в: : | Int J Clin Pharmacol Ther |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dustri-Verlag Dr. Karl Feistle
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5100660/ https://ncbi.nlm.nih.gov/pubmed/27668697 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5414/CP202623 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|